@drelinorchapman.bsky.social
Pinned
Wow! What a 12 months! I have loved working with @livuni-ismib.bsky.social @livunihls.bsky.social @liverpooluni.bsky.social. Thankful for all the colleagues in this photo who have taught me so much this past 12 months. Every single one of them has helped me in different ways. Here's to 2025.
Reposted
Did you ever notice, many of our tiled columns appear the same, but are in fact different? What other 'same but different' shapes have you noticed?
📌 Learn more about Waterhouse and his tremendous tiles every Tuesday at 2pm on one of our popular FREE guided tours.
🔗 https://orlo.uk/djlZQ
📌 Learn more about Waterhouse and his tremendous tiles every Tuesday at 2pm on one of our popular FREE guided tours.
🔗 https://orlo.uk/djlZQ
November 6, 2025 at 8:00 AM
Did you ever notice, many of our tiled columns appear the same, but are in fact different? What other 'same but different' shapes have you noticed?
📌 Learn more about Waterhouse and his tremendous tiles every Tuesday at 2pm on one of our popular FREE guided tours.
🔗 https://orlo.uk/djlZQ
📌 Learn more about Waterhouse and his tremendous tiles every Tuesday at 2pm on one of our popular FREE guided tours.
🔗 https://orlo.uk/djlZQ
Work published in @commsmed.bsky.social
New funding for major research study to find a way to predict when cancer patients will die, with preliminary research into creating a tool to identify the dying process published in @natureportfolio.nature.com Communications Medicine ⬇️
news.liverpool.ac.uk/2025/02/27/s...
@livunihls.bsky.social
news.liverpool.ac.uk/2025/02/27/s...
@livunihls.bsky.social
March 3, 2025 at 10:09 AM
Work published in @commsmed.bsky.social
I was heavily involved in and am proud of this work.
New funding for major research study to find a way to predict when cancer patients will die, with preliminary research into creating a tool to identify the dying process published in @natureportfolio.nature.com Communications Medicine ⬇️
news.liverpool.ac.uk/2025/02/27/s...
@livunihls.bsky.social
news.liverpool.ac.uk/2025/02/27/s...
@livunihls.bsky.social
March 3, 2025 at 10:08 AM
I was heavily involved in and am proud of this work.
Wow! What a 12 months! I have loved working with @livuni-ismib.bsky.social @livunihls.bsky.social @liverpooluni.bsky.social. Thankful for all the colleagues in this photo who have taught me so much this past 12 months. Every single one of them has helped me in different ways. Here's to 2025.
December 19, 2024 at 5:00 PM
Wow! What a 12 months! I have loved working with @livuni-ismib.bsky.social @livunihls.bsky.social @liverpooluni.bsky.social. Thankful for all the colleagues in this photo who have taught me so much this past 12 months. Every single one of them has helped me in different ways. Here's to 2025.
Reposted
New in the December 19/26, 2024, issue of NEJM:
Ponsegromab for Cancer Cachexia (phase 1B study) nej.md/3XE645a
Levofloxacin and Multidrug-Resistant Tuberculosis (VQUIN MDR trial) nej.md/41BHEf5
Levofloxacin Preventive Therapy for MDR Tuberculosis (TB-CHAMP trial) nej.md/41AXgQd
#MedSky
Ponsegromab for Cancer Cachexia (phase 1B study) nej.md/3XE645a
Levofloxacin and Multidrug-Resistant Tuberculosis (VQUIN MDR trial) nej.md/41BHEf5
Levofloxacin Preventive Therapy for MDR Tuberculosis (TB-CHAMP trial) nej.md/41AXgQd
#MedSky
December 19, 2024 at 2:34 PM
New in the December 19/26, 2024, issue of NEJM:
Ponsegromab for Cancer Cachexia (phase 1B study) nej.md/3XE645a
Levofloxacin and Multidrug-Resistant Tuberculosis (VQUIN MDR trial) nej.md/41BHEf5
Levofloxacin Preventive Therapy for MDR Tuberculosis (TB-CHAMP trial) nej.md/41AXgQd
#MedSky
Ponsegromab for Cancer Cachexia (phase 1B study) nej.md/3XE645a
Levofloxacin and Multidrug-Resistant Tuberculosis (VQUIN MDR trial) nej.md/41BHEf5
Levofloxacin Preventive Therapy for MDR Tuberculosis (TB-CHAMP trial) nej.md/41AXgQd
#MedSky